The Tisch Cancer Institute at Mount Sinai is a leader in translating clinical research into cancer immunotherapies for patients. PICI researcher Nina Bhardwaj, MD, PhD, at Mount Sinai is an expert who contributes foundational insights in understanding patient responses to immunotherapy treatments. She closely examines immune behavior to test and develop cancer-curing vaccines. Bhardwaj is instrumental on several PICI research projects and clinical trials, with a focus on prostate and pancreatic cancers. Nina Bhardwaj, MD, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Research Project Brain Tumor Program Point of View How to Engage Your Employees During a Pandemic Our Impact, Patient Story A Legacy of Service and a New Day for Pancreatic Cancer Cancer Research Heroes, Our Impact The Power and Promise of High-Risk Science Announcement, Our Impact, Press Release, Research Update Neoantigen Alliance IDs Parameters for Cancer Vaccines Announcement, Press Release PICI Appoints John Connolly as Chief Scientific Officer Research Project CANDEL: A first-of-its-kind data analysis engine for scientific discovery
Announcement, Our Impact, Press Release, Research Update Neoantigen Alliance IDs Parameters for Cancer Vaccines